Taken together, Dnmt1 silencing in ECs produces whole-scale changes in the tumor immune microenvironment, including an unexpected reduction in CD11c+ dendritic cells, increases in CD8+ T-cells, including those associated with and extravasating the vasculature, and significant increases in GzB+ cytolytic cells. This evidence concerns the gene DNMT1 and neoplasm.